DB Fitzpatrick & Co Inc lessened its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 1.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,413 shares of the semiconductor company’s stock after selling 45 shares during the quarter. DB Fitzpatrick & Co Inc’s holdings in Synopsys were worth $1,171,000 as of its most recent SEC filing.
A number of other large investors have also recently made changes to their positions in the stock. Parnassus Investments LLC purchased a new position in Synopsys in the third quarter worth about $633,469,000. Edgewood Management LLC boosted its holdings in shares of Synopsys by 18.9% in the third quarter. Edgewood Management LLC now owns 3,069,848 shares of the semiconductor company’s stock worth $1,554,540,000 after buying an additional 487,025 shares during the last quarter. Van ECK Associates Corp boosted its holdings in shares of Synopsys by 26.5% in the third quarter. Van ECK Associates Corp now owns 1,605,001 shares of the semiconductor company’s stock worth $791,923,000 after buying an additional 335,993 shares during the last quarter. Impax Asset Management Group plc increased its holdings in Synopsys by 120.2% during the third quarter. Impax Asset Management Group plc now owns 490,723 shares of the semiconductor company’s stock valued at $248,497,000 after buying an additional 267,836 shares during the last quarter. Finally, Wellington Management Group LLP raised its position in Synopsys by 32.5% in the third quarter. Wellington Management Group LLP now owns 1,048,709 shares of the semiconductor company’s stock worth $531,056,000 after acquiring an additional 257,526 shares during the period. 85.47% of the stock is currently owned by institutional investors.
Insider Buying and Selling at Synopsys
In other news, CRO Richard S. Mahoney sold 20,838 shares of the company’s stock in a transaction that occurred on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the sale, the executive now directly owns 1,460 shares of the company’s stock, valued at $738,774.60. This represents a 93.45 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.66% of the company’s stock.
Analyst Ratings Changes
Check Out Our Latest Research Report on SNPS
Synopsys Stock Performance
SNPS opened at $526.70 on Friday. The stock has a market capitalization of $81.42 billion, a price-to-earnings ratio of 36.27, a PEG ratio of 3.22 and a beta of 1.12. The company has a fifty day moving average of $519.43 and a 200 day moving average of $526.69. Synopsys, Inc. has a fifty-two week low of $457.52 and a fifty-two week high of $629.38.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading
- Five stocks we like better than Synopsys
- Insider Trades May Not Tell You What You Think
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- Basic Materials Stocks Investing
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- Stock Market Sectors: What Are They and How Many Are There?
- MarketBeat Week in Review – 01/13 – 01/17
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.